AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

5,241.00p
   
  • Change Today:
    -104.00p
  • 52 Week High: 5,508.00
  • 52 Week Low: 4,325.00
  • Currency: UK Pounds
  • Shares Issued: 1,266.61m
  • Volume: 3,413,560
  • Market Cap: 66,383m
  • RiskGrade: 79

AstraZeneca Overview

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

AstraZeneca Financials

Latest F'cast
Div Yield 4.0% 3.8%
Div Cover 1.5 1.2
Op Mrgn 18.2% 22.5%
ROCE 465.6%  
Latest F'cast
P/E 16.5 21.3
PEG n/a n/a
Pr/Revenue 4.4 4.1
Pr/Book 5.4  
Latest F'cast
Revenue -5.5% -40.0%
PBT -37.3% 22.2%
EPS -0.7% -22.0%
DPS n/a -46.3%

AstraZeneca Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-13 25,711.00 3,267.00 505.00¢ 9.5 n/a -26% 280.00¢ 5.8%
31-Dec-14 26,095.00 1,246.00 428.00¢ 14.3 n/a -15% 280.00¢ 4.6%
31-Dec-15 23,641.00 3,069.00 426.00¢ 14.6 n/a -0% 280.00¢ 4.5%
31-Dec-16 21,319.00 3,552.00 431.00¢ 13.9 13.9 +1% 280.00¢ 4.7%
31-Dec-17 20,152.00 2,227.00 428.00¢ 16.1 n/a -1% 280.00¢ 4.1%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

AstraZeneca Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 16,275.87 3,665.74 246.35p 21.3 n/a -22% 202.68p 3.8%
31-Dec-19 17,354.85 4,161.27 280.30p 18.7 1.4 +14% 205.69p 3.9%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

AstraZeneca Company Announcements

Result of AGM 18-May-2018 17:30 RNS
AZN: Q1 2018 Results 18-May-2018 07:00 RNS
AstraZeneca update on Fasenra PIII trial in COPD 11-May-2018 07:00 RNS

Latest AstraZeneca Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 5,241.00p
Change Today -104.00p
% Change -1.95 %
52 Week High 5,508.00
52 Week Low 4,325.00
Volume 3,413,560
Shares Issued 1,266.61m
Market Cap 66,383m
RiskGrade 79

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
12.61% above the market average12.61% above the market average12.61% above the market average12.61% above the market average12.61% above the market average
96.83% above the sector average96.83% above the sector average96.83% above the sector average96.83% above the sector average96.83% above the sector average
Price Trend
35.63% above the market average35.63% above the market average35.63% above the market average35.63% above the market average35.63% above the market average
28.12% above the sector average28.12% above the sector average28.12% above the sector average28.12% above the sector average28.12% above the sector average
Income
50.38% above the market average50.38% above the market average50.38% above the market average50.38% above the market average50.38% above the market average
83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average
Growth
84.59% below the market average84.59% below the market average84.59% below the market average84.59% below the market average84.59% below the market average
95.24% below the sector average95.24% below the sector average95.24% below the sector average95.24% below the sector average95.24% below the sector average

What The Brokers Say

Strong Buy 22
Buy 3
Neutral 8
Sell 0
Strong Sell 3
Total 36
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 09-Aug-18 15-Feb-18
Paid 10-Sep-18 19-Mar-18
Amount 90.00¢ 190.00¢

Trades for 18-May-2018

Time Volume / Share Price
17:07 9,518 @ 5,225.84p
17:07 17 @ 5,225.85p
17:07 2,248 @ 5,225.84p
17:07 842 @ 5,225.84p
17:07 2,299 @ 5,225.84p

Top of Page